U.S. Banks Stock News

Geopolitics is back on centre stage, with the threat of U.S. sanctions on Chinese banks tied to Iranian oil flows rippling through expectations for crude supply, currency stability and global risk appetite. That mix can create sharp winners and losers. This article walks through three large integrated oil and gas stocks from our Global Majors screener that are closely exposed to this news, and explains why each might deserve a closer look right now. The three stocks below are just a starting...

Critical Metals stock moves after recent performance swings Critical Metals (CRML) has drawn fresh attention after sharp recent share price swings. The stock is up about 15% over the past month but down roughly 43% in the past 3 months. See our latest analysis for Critical Metals. For investors tracking the wider trend, Critical Metals has a mixed profile, with a 14.8% 30 day share price return but a 3 year total shareholder return that declined 38.35%. This suggests that momentum may be...

KeyCorp preferred stock redemption sets the context for NYSE:KEY KeyCorp (KEY) has notified holders that it plans to redeem all 525,000 depositary shares of its Series D preferred stock on September 15, 2026, for cash at the specified redemption price. See our latest analysis for KeyCorp. At a share price of $21.87, KeyCorp has seen a 7 day share price return that declined 5.08% and a 30 day share price return that declined 3.44%, while its 1 year total shareholder return of 19.85% and 3 year...

C.H. Robinson Worldwide (CHRW) has drawn investor attention after recent trading left the stock down about 23% over the past month and 20% over the past 3 months, despite positive trailing multi year total returns. See our latest analysis for C.H. Robinson Worldwide. At a latest share price of US$142.86, C.H. Robinson Worldwide has seen its short term share price momentum fade, with the 30 day share price return down 23.4% and the year to date share price return down 12.7%. However, the 5...

Humana (NYSE:HUM) and DaVita have launched a new coordinated value-based care partnership for Medicare Advantage members with chronic kidney disease. The program targets over 10,000 Medicare Advantage members and focuses on earlier intervention to slow disease progression and reduce hospitalizations. The collaboration expands Humana's value-based care model by integrating DaVita's kidney care expertise into Humana's existing Medicare Advantage footprint. For investors tracking how health...

Escalating tariff threats between the U.S. and Canada are putting a fresh spotlight on auto and industrial manufacturers that rely on cross border trade. When policy risk reshapes supply chains, some stocks can feel pressure while others may gain an edge. This article looks at three U.S. focused manufacturers exposed to the current trade headlines and explains how the news could matter for their businesses and for your watchlist. The stocks covered below are just a small sample of what this...

Baird recently upgraded Darden Restaurants to Outperform as part of a wider reshuffle of its restaurant coverage, citing the company’s strong execution, relevant marketing and role as a core casual dining holding. The move underscores how, in tougher operating conditions for restaurants, investors may be favoring operators viewed as having more resilient growth frameworks. Next, we’ll examine how Baird’s vote of confidence in Darden’s execution and brand strength could influence its existing...

Horace Mann Educators has almost doubled shareholders' money over the past three years, yet the latest intrinsic value work using the Excess Returns model suggests the stock trades at a premium to that estimate while traditional earnings multiples look roughly in line with peers. The stock has returned 97.2% over the past three years, which puts extra focus on whether the current price already reflects much of the good news in the story. Future cash flow and earnings can benefit if Horace...

CarGurus stock moves draw attention after recent performance CarGurus (CARG) has attracted fresh interest after a strong recent run in its share price, with the stock closing at US$37.21 and recording double digit returns over the past month and over the past 3 months. See our latest analysis for CarGurus. Zooming out, CarGurus now trades at US$37.21 with a 30 day share price return of 11.51% and a 90 day share price return of 33.90%, while the 1 year total shareholder return is 9.09%. The 3...

10x Genomics stock has delivered a very strong 353.4% return over the past year, yet broader valuation checks suggest the shares are not a clear bargain at current levels. With expectations high around its Atera spatial biology platform and expanding clinical collaborations, the key issue for investors is whether the recent price move already reflects much of that optimism. Over the last 12 months, 10x Genomics has returned 353.4%, which puts extra focus on whether recent gains leave much...

Rocket Companies recently added Sarah Watterson as an independent director, expanding its board to 10 members and bringing extensive experience across investment, capital markets, transportation, real estate, and sports and entertainment operations. At the same time, a settlement allowing Redfin to keep its core rental-listing economics with Zillow while regaining freedom to grow its own rentals advertising business meaningfully shifts how Rocket can approach the multifamily rentals...

Harley-Davidson (HOG) has drawn fresh attention after its recent share price move, with the stock closing at $28.29 as of 24 August 2026. Investors are reassessing the motorcycle maker’s value, business mix, and recent financial trends. See our latest analysis for Harley-Davidson. Harley-Davidson’s recent share price momentum has been firm, with a 7 day share price return of 4.66% and a year to date share price return of 37.06%, although the 5 year total shareholder return of 20.88% shows...

Lockheed Martin (NYSE:LMT) recently ran a major live trial of its NetSense AI-enabled Airspace Awareness-as-a-Service system, using commercial 5G networks to track unmanned aircraft systems in real time. The NetSense trial highlighted a service model aimed at scalable, lower cost protection for critical infrastructure and sensitive airspace. Lockheed Martin expanded its work with Firefly Aerospace into a multi-year block of dedicated rocket launches. The partnership now also covers...

Over the last 7 days, the United States market has experienced a slight decline of 1.5%, yet it has shown robust growth over the past year with an increase of 18%, and earnings are expected to continue growing at a rate of 17% annually. In this context, identifying stocks that are estimated to be below their fair value can be particularly appealing for investors seeking potential opportunities amidst fluctuating market conditions.

Over the last 7 days, the United States market has dropped 1.5%, yet it has shown resilience with an 18% increase over the past year and an annual earnings growth forecast of 17%. In such a fluctuating environment, growth stocks with high insider ownership can be appealing as they often indicate strong confidence from those closest to the company in its long-term potential.

Over the last 7 days, the U.S. market has dropped 1.5%, but it has risen by 18% over the past year, with earnings forecasted to grow by 17% annually. For investors willing to explore beyond established names, penny stocks—often smaller or newer companies—can present intriguing opportunities despite their somewhat outdated label. By focusing on those with strong financials and a clear growth path, investors can discover promising options that balance potential upside with stability.

Moody’s recent affirmation of Las Vegas Sands (LVS) credit ratings with a stable outlook has put the stock back in focus for investors watching casino operators with large Asian resort exposure. See our latest analysis for Las Vegas Sands. Despite Moody’s affirmation, Las Vegas Sands’ share price has been under pressure, with the stock down 28% year to date and the 1 year total shareholder return declining 15%, signalling fading momentum even as credit confidence remains intact. If you are...

Arcus Biosciences (RCUS) continues to attract attention after recent share price moves, with the stock closing at US$30.12. Investors are weighing its clinical-stage cancer pipeline and its latest trading performance. See our latest analysis for Arcus Biosciences. The recent move to US$30.12 comes after a mixed near term patch, with the 1-day share price return slightly down, but a 90-day share price return of 24.82% and a 1-year total shareholder return of 196.75% point to strong underlying...

In August 2026, Eton Pharmaceuticals reported second-quarter 2026 results showing revenue of US$37.59 million and net income of US$11.58 million, reversing a loss in the prior-year period and turning earnings per share from a loss to US$0.35 on a diluted basis. Alongside this earnings improvement, the company raised its 2026 annual revenue guidance to at least US$145 million, suggesting management sees the recent performance as part of a broader shift in its operating profile. With this...

Corpay’s European T20 Premier League Agreement Corpay (CPAY) has secured a new client agreement with the European T20 Premier League, becoming the tournament’s exclusive foreign exchange partner and provider of FX risk management and global payments solutions. See our latest analysis for Corpay. The new European T20 Premier League agreement comes as Corpay’s share price sits at US$413.92, with a 30-day share price return of 11.70% and a 90-day share price return of 18.39%. Over longer...

As the U.S.-Canada trade war heats up, with fresh 50% tariffs and warnings about energy and critical minerals, utilities and power generators are suddenly on the front line of a political story that hits real assets and real bills. For investors, stress in cross-border supply chains can reshape where money flows. This article walks through 3 stocks exposed to this news so you can judge the risks and potential resilience. The three stocks covered next are only a starting point, and the full...

Proto Labs has appointed manufacturing veteran Sam Ramahi as Chief Operations Officer, effective August 31, 2026, to oversee global operations, supply chain, quality, sourcing, and continuous improvement under CEO Suresh Krishna’s oversight. Investors are watching how Ramahi’s 25-plus years of transforming complex manufacturing and supply chain organizations might influence Proto Labs’ push to support customers from prototype through production. Next, we’ll examine how Ramahi’s oversight of...

How Marzetti’s latest earnings, buyback and dividend fit together for shareholders Marzetti (MZTI) just reported fourth quarter and full year results alongside a fresh update on its long running buyback and a new quarterly dividend declaration. That combination gives you several angles to assess the stock. For the quarter ended June 30, 2026, Marzetti reported sales of US$465.03 million compared with US$475.43 million a year earlier. Net income was US$48.29 million compared with US$32.53...

Concentra Group Holdings Parent, Inc. announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, rejoined the company on September 1, 2026, and became chief medical officer on January 1, 2027, succeeding longtime CMO Dr. John Anderson after his 33-year tenure. Her combination of clinical leadership at Zenith Insurance Company and presidency of the American College of Occupational and Environmental Medicine brings a rare blend of payer and provider insight to...